Fig. 5From: Utility of VS38c in the diagnostic and prognostic assessment of osteosarcoma and other bone tumours/tumour-like lesionsImmunohistochemistry with monoclonal antibody VS38c of an osteosarcoma that had received neoadjuvant therapy showing: a low and b high-power views of VS38c staining of residual viable tumour (right) and absence of staining in necrotic areas of tumour (left) (original magnification: a ×100; b ×400)Back to article page